BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34129933)

  • 21. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and validation of a novel ferroptosis-related gene model for predicting the prognosis of gastric cancer patients.
    Liu G; Ma JY; Hu G; Jin H
    PLoS One; 2021; 16(7):e0254368. PubMed ID: 34252149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel ferroptosis-related lncRNA signature for prognosis prediction in gastric cancer.
    Wei J; Zeng Y; Gao X; Liu T
    BMC Cancer; 2021 Nov; 21(1):1221. PubMed ID: 34774009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer.
    Wu J; Wang X; Wang N; Ma L; Xie X; Zhang H; Kang H; Zhou Z
    World J Surg Oncol; 2021 Jul; 19(1):219. PubMed ID: 34284774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer.
    Qiu F; Zhu Y; Shi Y; Ji J; Jin Y
    Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A signature of 14 immune-related gene pairs predicts overall survival in gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Transl Oncol; 2021 Feb; 23(2):265-274. PubMed ID: 32519178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
    Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
    Front Immunol; 2021; 12():719628. PubMed ID: 34413861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
    Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
    Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a five-lncRNA signature for the diagnosis and prognosis of gastric cancer.
    Fan ZY; Liu W; Yan C; Zhu ZL; Xu W; Li JF; Su L; Li C; Zhu ZG; Liu B; Yan M
    Tumour Biol; 2016 Oct; 37(10):13265-13277. PubMed ID: 27460075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
    Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
    Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A nomogram for prediction of stage III/IV gastric cancer outcome after surgery: A multicenter population-based study.
    Gao Z; Ni J; Ding H; Yan C; Ren C; Li G; Pan F; Jin G
    Cancer Med; 2020 Aug; 9(15):5490-5499. PubMed ID: 32543092
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
    Zheng S; Zhang Z; Ding N; Sun J; Lin Y; Chen J; Zhong J; Shao L; Lin Z; Xue M
    BMC Gastroenterol; 2021 Apr; 21(1):146. PubMed ID: 33794777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Novel RNA-Binding Protein-Based Nomogram for Predicting Survival of Patients with Gastric Cancer.
    Zhu M; Cai J; Wu Y; Wu X; Feng L; Yin Z
    Med Sci Monit; 2021 Jan; 27():e928195. PubMed ID: 33471782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic Nomogram for Overall Survival in Small Cell Lung Cancer Patients Treated with Chemotherapy: A SEER-Based Retrospective Cohort Study.
    Liang M; Chen M; Singh S; Singh S
    Adv Ther; 2022 Jan; 39(1):346-359. PubMed ID: 34729705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
    Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
    Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nomogram Based on microRNA Signature Contributes to Improve Survival Prediction of Clear Cell Renal Cell Carcinoma.
    Zhao E; Bai X
    Biomed Res Int; 2020; 2020():7434737. PubMed ID: 32280701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
    Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
    Front Genet; 2021; 12():661306. PubMed ID: 34249086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new risk model based on a 11-m
    Lei L; Li N; Yuan P; Liu D
    BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.